Search Results - "van Dongen, J.A."

The Risk of a Bicycle Helmet: Hyoid Bone Fracture by van Dongen, Mariska J.A, Falger-Veeken, Susanne N

Get full text

The rainbow scale for the assessment of dermatochalasis of the female upper eyelid: A validated scale by Mooij, J.J., van de Lande, L.S., Pool, S.M.W., Stevens, H.P.J.D., van der Lei, B., van Dongen, J.A.

Get full text

Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM) by van Tienhoven, G, Voogd, A.C, Peterse, J.L, Nielsen, M, Andersen, K.W, Mignolet, F, Sylvester, R, Fentiman, I.S, van der Schueren, E, van Zijl, K, Blichert-Toft, M, Bartelink, H, van Dongen, J.A

“…The aim of this study was to investigate and compare the prognosis after treatment for loco-regional recurrences (LR) after (modified) radical mastectomy (MRM)…”
Get full text

Emmanuel van der Schueren lecture: E1. Art and breast cancer by van Dongen, J.A.

Get full text

Methionine requirement of the enterally fed term infant in the first month of life in the presence of cysteine by LISHA HUANG, HOGEWIND-SCHOONENBOOM, Jacomine E, VAN GOUDOEVER, Johannes B, VAN DONGEN, Mariska Ja, DE GROOF, Femke, VOORTMAN, Gardi J, SCHIERBEEK, Henk, TWISK, Jos Wr, VERMES, Andras, CHAO CHEN, YING HUANG

“…The essential amino acid methionine can be used for protein synthesis but also serves as a precursor for homocysteine and cysteine. The objective of this study…”
Get full text

Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer by van Dongen, J A, Bartelink, H, Fentiman, I S, Lerut, T, Mignolet, F, Olthuis, G, van der Schueren, E, Sylvester, R, Tong, D, Winter, J

“…A (modified) radical mastectomy (RM) was compared with breast-conserving therapy (BCT) in stage I and stage II breast cancer patients. Treatment of the study…”
Get more information

1020 DCIS of the breast, the challenge to find the right treatment. Biology and chronology by van Dongen, J.A.

“…With the improvements of mammography and the broad introduction of screening in countries with a high breast cancer incidence the number of cases of in situ…”
Get full text

Locoregional recurrence (LRR) after breastconserving therapy (BCT): diagnosis, treatment and impact on survival by Van Dongen, J.A.

Get full text

Identification and biopsy of the sentinel lymph node in breast cancer by Kapteijn, B.A.E., Nieweg, O.E., Petersen, J.L., Rutgers, E.J.Th, Hart, A.A.M., van Dongen, J.A., Kroon, B.B.R.

“…To examine the hypothesis that lymphatic dissemination in breast cancer occurs sequentially. Thirty patients with clinically localized adenocarcinoma were…”
Get full text

Variations in diagnostic and therapeutic procedures in a multicentre, randomized clinical trial (EORTC 10853) investigating breast-conserving treatment for DCIS by Bijker, N., Rutgers, E.J.T., Peterse, J.L., Fentiman, I.S., Julien, J.-P., Duchateau, L., van Dongen, J.A.

“…Aims To evaluate the diagnostic and therapeutic procedures which were followed in a European Organization for Research and Treatment of Cancer (EORTC)…”
Get full text

Is mass screening for breast cancer cost-effective? by van Dongen, J.A.

Get full text

The impact of tumor size and histology on local control after breast-conserving therapy by Bartelink, H, Borger, J H, van Dongen, J A, Peterse, J L

“…To investigate possible contraindications for breast-conserving therapy (BCT) a retrospective clinicopathological study was carried out in 585 patients treated…”
Get more information

Ductal carcinoma in-situ of the breast; second EORTC consensus meeting by van Dongen, J A, Holland, R, Peterse, J L, Fentiman, I S, Lagios, M D, Millis, R R, Recht, A

Get more information

PP-3-8 Prognosis after salvage treatment for local-regional recurrence of mastectomy or breast conservation in eortic trial 10801 by van Tienhoven, G., Voogd, A.C., van Dongen, J.A.

Get full text

The usefulness of screening data for studying the biology of breast cancer by van Dongen, J.A.

Get full text

Long-term functional morbidity after mild hyperthermic isolated limb perfusion with melphalan by Vrouenraets, B, C., in »t Veld, G.J., Nieweg, O.E., van Slooten, G.W., van Dongen, J.A., Kroon, B.B.R.

“…Aims: To assess long-term functional morbidity in patients entered in the prospective randomized EORTC trial investigating the role of adjuvant isolated limb…”
Get full text

Are risk factors for local and distant recurrence following breast-conserving therapy for early breast cancer similar to those following mastectomy? by Voogd, A.C., Nielsen, M., Peterse, J.L., Blichert-Toft, M., Bartelink, H., van Tienhoven, G., Andersen, K. West, Sylvester, R., van Dongen, J.A.

Get full text

Is mass screening for breast cancer cost-effective? by de Koning Contra, HJ, Arbiter, J.W.W.Coebergh, van Dongen, J.A.

Get full text

Third meeting of the DCIS Working Party of the EORTC (Fondazione Cini, Isola S. Giorgio, Venezia, 28 February 1994)--Conference report by Recht, A, van Dongen, J A, Fentiman, I S, Holland, R, Peterse, J L

Get more information

Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial by Van Dongen, J.A, Voogd, A.C, Fentiman, I.S, Legrand, C, Sylvester, R.J, Tong, D, Van der Schueren, E

Get full text